Color, today announced a $167 million Series D financing round. The round was led by General Catalyst and funds and accounts advised by T. Rowe Price Associates, Inc., with participation from Viking Global Investors and others.
The health tech company has raised $278 million in total financing, with a valuation of $1.5 billion. The company will use the funding to expand its work building public health technology and infrastructure for governments, employers, and other institutions that serve large populations.
“We are building the rails for a national technology-based public health infrastructure,” said Color CEO Othman Laraki. “A modern public health infrastructure should enable all of the stakeholders in the health of large populations – including governments, employers, and schools – to support the essential health needs of the people they serve. By investing in the technology that ensures easy and affordable access to healthcare, we’re creating the infrastructure that will serve us for decades to come.”
Color’s infrastructure and software are making it possible for large populations to receive essential healthcare services directly where they live or work. In response to the COVID-19 pandemic, Color has partnered with more than 100 major employers and universities to provide critical testing programs.
Color has also made several key additions to its leadership team. It has announced Claire Vo as Chief Product Officer, Emily Reuter as Vice President of Strategy & Operations, and Ashley Chandler as Vice President of Marketing.